Galenica AG
Galenica AG (GALE.SW) Stock Overview
Explore Galenica AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.4B
P/E Ratio
23.87
EPS (TTM)
$3.67
ROE
0.12%
GALE.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Galenica AG (GALE.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $82.05.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.87 and a market capitalization of 4.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
Marc Werner
4,511
Untermattweg 8, Bern
2017